Scarista Limited
Records under this name other than patents Scarista Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,331,568 | Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid Term ended Term ended Jun 10, 2019 · USPTO record | Term ended | Term ended Jun 10, 2019 | USPTO record |
| US 6,191,133 | Treatment of depression and pharmaceutical preparations therefor Formerly held Term ended Term ended Jun 24, 2018 · USPTO record | Term ended | Term ended Jun 24, 2018 | USPTO record |
| US 6,015,821 | Nicotinic acid esters and pharmaceutical compositions containing them Term ended Term ended Mar 3, 2018 · USPTO record | Term ended | Term ended Mar 3, 2018 | USPTO record |
| US 6,150,411 | Use of DHA as a pharmaceutical composition Term ended Term ended Feb 28, 2017 · USPTO record | Term ended | Term ended Feb 28, 2017 | USPTO record |
| US RE40,480 | 1,3-Propane diol esters and ethers and methods for their use in drug delivery Term ended Term ended May 1, 2016 · USPTO record | Term ended | Term ended May 1, 2016 | USPTO record |
| US RE40,546 | 1,3-Propane diol esters and ethers and methods for their use in drug delivery Term ended Term ended May 1, 2016 · USPTO record | Term ended | Term ended May 1, 2016 | USPTO record |
| US 6,624,195 | Pharmaceutical Preparation Comprising Eicosapentaenoic Acid And/Or Stearidonic Acid Lapsed on the fee record Ended Sep 23, 2015 · Medium confidence | Lapsed on the fee record | Ended Sep 23, 2015 | Medium confidence |
| US 6,245,811 | Fatty acid esters as bioactive compounds Lapsed on the fee record Ended Jun 12, 2013 · USPTO record | Lapsed on the fee record | Ended Jun 12, 2013 | USPTO record |
| US RE43,632 | 1,3-propane diol esters and ethers and methods for their use in drug delivery Lapsed on the fee record Ended Apr 29, 2011 · USPTO record | Lapsed on the fee record | Ended Apr 29, 2011 | USPTO record |
| US 6,184,251 | Use of arachidonic acid and/or docosahexanoic acid for the treatment of dyspraxia Lapsed on the fee record Ended Feb 6, 2009 · USPTO record | Lapsed on the fee record | Ended Feb 6, 2009 | USPTO record |